-
1
-
-
84861543083
-
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
-
Chalasani N, Younossi Z, Lavine JE, et al: The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55: 2005-2023, 2012.
-
(2012)
Hepatology
, vol.55
, pp. 2005-2023
-
-
Chalasani, N.1
Younossi, Z.2
Lavine, J.E.3
-
2
-
-
84879025309
-
Evaluation of waist circumference cut-off values as a marker for fatty liver among Japanese workers
-
Abe N, Honda S and Jahng D: Evaluation of waist circumference cut-off values as a marker for fatty liver among Japanese workers. Saf Health Work 3: 287-293, 2012.
-
(2012)
Saf Health Work
, vol.3
, pp. 287-293
-
-
Abe, N.1
Honda, S.2
Jahng, D.3
-
3
-
-
22344452893
-
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
-
Adams LA, Lymp JF, St Sauver J, et al: The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129: 113-121, 2005.
-
(2005)
Gastroenterology
, vol.129
, pp. 113-121
-
-
Adams, L.A.1
Lymp, J.F.2
st Sauver, J.3
-
4
-
-
50649094716
-
Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study
-
Dunn W, Xu R, Wingard DL, et al: Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 103: 2263-2271, 2008.
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 2263-2271
-
-
Dunn, W.1
Xu, R.2
Wingard, D.L.3
-
5
-
-
77952730428
-
The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
-
Ascha MS, Hanouneh IA, Lopez R, et al: The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 51: 1972-1978, 2010.
-
(2010)
Hepatology
, vol.51
, pp. 1972-1978
-
-
Ascha, M.S.1
Hanouneh, I.A.2
Lopez, R.3
-
6
-
-
84857984149
-
Dyslipidemia in patients with nonalcoholic fatty liver disease
-
Chatrath H, Vuppalanchi R and Chalasani N: Dyslipidemia in patients with nonalcoholic fatty liver disease. Semin Liver Dis 32: 22-29, 2012.
-
(2012)
Semin Liver Dis
, vol.32
, pp. 22-29
-
-
Chatrath, H.1
Vuppalanchi, R.2
Chalasani, N.3
-
7
-
-
80555136061
-
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
-
Musso G, Gambino R, Cassader M and Pagano G: Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 43: 617-649, 2011.
-
(2011)
Ann Med
, vol.43
, pp. 617-649
-
-
Musso, G.1
Gambino, R.2
Cassader, M.3
Pagano, G.4
-
8
-
-
84876187637
-
Quantitative measurement of ultrasound attenuation and hepato-renal index in non-alcoholic fatty liver disease
-
von Volkmann HL, Havre RF, Løberg EM, et al: Quantitative measurement of ultrasound attenuation and hepato-renal index in non-alcoholic fatty liver disease. Med Ultrason 15: 16-22, 2013.
-
(2013)
Med Ultrason
, vol.15
, pp. 16-22
-
-
von Volkmann, H.L.1
Havre, R.F.2
Løberg, E.M.3
-
9
-
-
84872686317
-
Review article: The diagnosis of non-alcoholic fatty liver disease - availability and accuracy of non-invasive methods
-
Festi D, Schiumerini R, Marzi L, et al: Review article: the diagnosis of non-alcoholic fatty liver disease - availability and accuracy of non-invasive methods. Aliment Pharmacol Ther 37: 392-400, 2013.
-
(2013)
Aliment Pharmacol Ther
, vol.37
, pp. 392-400
-
-
Festi, D.1
Schiumerini, R.2
Marzi, L.3
-
10
-
-
77956639983
-
NASH Clinical Research Network: Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease
-
Neuschwander-Tetri BA, Clark JM, Bass NM, et al; NASH Clinical Research Network: Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology 52: 913-924, 2010.
-
(2010)
Hepatology
, vol.52
, pp. 913-924
-
-
Neuschwander-Tetri, B.A.1
Clark, J.M.2
Bass, N.M.3
-
11
-
-
0032718310
-
International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis
-
Alvarez F, Berg PA, Bianchi FB, et al: International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31: 929-938, 1999.
-
(1999)
J Hepatol
, vol.31
, pp. 929-938
-
-
Alvarez, F.1
Berg, P.A.2
Bianchi, F.B.3
-
12
-
-
67651160903
-
American Association for Study of Liver Diseases: Primary biliary cirrhosis
-
Lindor KD, Gershwin ME, Poupon R, et al; American Association for Study of Liver Diseases: Primary biliary cirrhosis. Hepatology 50: 291-308, 2009.
-
(2009)
Hepatology
, vol.50
, pp. 291-308
-
-
Lindor, K.D.1
Gershwin, M.E.2
Poupon, R.3
-
13
-
-
34249819694
-
Exposure to a high total dosage of glucocorticoids produces non-alcoholic steatohepatits
-
Matsumoto T, Yamasaki S, Arakawa A, et al: Exposure to a high total dosage of glucocorticoids produces non-alcoholic steatohepatits. Pathol Int 57: 388-389, 2007.
-
(2007)
Pathol Int
, vol.57
, pp. 388-389
-
-
Matsumoto, T.1
Yamasaki, S.2
Arakawa, A.3
-
14
-
-
84855651987
-
Incidence of liver toxicity in inflammatory bowel disease patients treated with methotrexate: A meta-analysis of clinical trials
-
Khan N, Abbas AM, Whang N, et al: Incidence of liver toxicity in inflammatory bowel disease patients treated with methotrexate: a meta-analysis of clinical trials. Inflamm Bowel Dis 18: 359-367, 2012.
-
(2012)
Inflamm Bowel Dis
, vol.18
, pp. 359-367
-
-
Khan, N.1
Abbas, A.M.2
Whang, N.3
-
15
-
-
0036829092
-
American Gastroenterological Association: AGA technical review on nonalcoholic fatty liver disease
-
Sanyal AJ; American Gastroenterological Association: AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123: 1705-1725, 2002.
-
(2002)
Gastroenterology
, vol.123
, pp. 1705-1725
-
-
Sanyal, A.J.1
-
16
-
-
21344449292
-
Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study
-
Bedogni G, Miglioli L, Masutti F, et al: Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42: 44-52, 2005.
-
(2005)
Hepatology
, vol.42
, pp. 44-52
-
-
Bedogni, G.1
Miglioli, L.2
Masutti, F.3
-
17
-
-
78449286054
-
A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients
-
Anty R, Iannelli A, Patouraux S, et al: A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients. Aliment Pharmacol Ther 32: 1315-1322, 2010.
-
(2010)
Aliment Pharmacol Ther
, vol.32
, pp. 1315-1322
-
-
Anty, R.1
Iannelli, A.2
Patouraux, S.3
-
18
-
-
84883722805
-
Eating a healthy lunch improves serum alanine aminotransferase activity
-
Iwamoto M, Yagi K, Yazumi K, et al: Eating a healthy lunch improves serum alanine aminotransferase activity. Lipids Health Dis 12: 134, 2013.
-
(2013)
Lipids Health Dis
, vol.12
, pp. 134
-
-
Iwamoto, M.1
Yagi, K.2
Yazumi, K.3
-
19
-
-
84865517060
-
Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34 346 subjects
-
Wu WC, Wu CY, Wang YJ, et al: Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34 346 subjects. Aliment Pharmacol Ther 36: 560-568, 2012.
-
(2012)
Aliment Pharmacol Ther
, vol.36
, pp. 560-568
-
-
Wu, W.C.1
Wu, C.Y.2
Wang, Y.J.3
-
20
-
-
84883759656
-
Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)
-
Verma S, Jensen D, Hart J and Mohanty SR: Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). Liver Int 33: 1398-1405, 2013.
-
(2013)
Liver Int
, vol.33
, pp. 1398-1405
-
-
Verma, S.1
Jensen, D.2
Hart, J.3
Mohanty, S.R.4
-
21
-
-
79956294683
-
Elevation of liver enzymes within the normal limits and metabolic syndrome
-
Xia MF, Yan HM, Lin HD, et al: Elevation of liver enzymes within the normal limits and metabolic syndrome. Clin Exp Pharmacol Physiol 38: 373-379, 2011.
-
(2011)
Clin Exp Pharmacol Physiol
, vol.38
, pp. 373-379
-
-
Xia, M.F.1
Yan, H.M.2
Lin, H.D.3
-
22
-
-
10844262508
-
Efficacy and effectiveness of liver screening program to detect fatty liver in the periodic health check-ups
-
Nomura K, Yano E, Shinozaki T and Tagawa K: Efficacy and effectiveness of liver screening program to detect fatty liver in the periodic health check-ups. J Occup Health 46: 423-428, 2004.
-
(2004)
J Occup Health
, vol.46
, pp. 423-428
-
-
Nomura, K.1
Yano, E.2
Shinozaki, T.3
Tagawa, K.4
-
23
-
-
84869166012
-
Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units
-
Hu X, Huang Y, Bao Z, et al: Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units. BMC Gastroenterol 12: 123, 2012.
-
(2012)
BMC Gastroenterol
, vol.12
, pp. 123
-
-
Hu, X.1
Huang, Y.2
Bao, Z.3
|